GEA is raising its outlook for sales, EBITDA before restructuring measures and return on capital employed (ROCE) for fiscal year 2021 as a result of a very good performance in the first half 2021 and increasingly effective efficiency measures. The new outlook exceeds the previously provided outlook as well as current capital market expectations (average values of the latest consensus estimates of financial analysts, published by Vara Research on July 29, 2021).
GEA adjusts its forecast for the fiscal year 2021 as follows:
- Sales is now expected to grow organically (adjusted for foreign exchange effects and acquisitions/divestments) by 5 to 7 percent (previously: 0-5%).
- EBITDA before restructuring measures (based on constant currencies) is now expected to be in a range of EUR 600 to 630 million (previously: Euro 530 to 580 million; consensus EUR 572 million)
- ROCE (based on constant currencies) is now expected to be in the range of 23 to 26 percent (previously: 16 to 20 percent).
GEA‘s outlook assumes that there will be no severe restrictions on economic activity due to measures to combat the Covid-19 pandemic in the second half of 2021.
In the second quarter of 2021 relevant preliminary financial figures developed as followed:
- Order intake increased significantly by 25.1 percent to EUR 1,294 million (organic growth: 30.2 percent; consensus: Euro 1,227 million)
- Sales declined slightly by 0.8 percent to EUR 1,156 million (organic growth: 3.4 percent; consensus: EUR 1,179 million)
- EBITDA before restructuring measures improved by 9.4 percent to Euro 153.7 million (consensus: EUR 145.6 million)
- ROCE increased significantly to 21.7 percent (prior year period: 14.8 percent)
The complete half-year financial report 2021 will be published on August 13, 2021.
Media Relations
GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476
Düsseldorf
Germany
+49 211 9136-0
Find out more
About GEA
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries.
The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated sales of about EUR 5.5 billion in more than 150 countries in the 2025 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the German DAX, the European STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.
